07 aug: Vestas/SEB: Sænker kursmål til 40 kr
07 aug: Danske Bank/CEO: Indtjeningen skal mere end fordobles
07-08-2012 12:40:00

Xstrata Able to Fund Capex Program and Maintain Dividend - CFO

Relateret indhold

By Alex MacDonald

LONDON--Anglo Swiss miner Xstrata PLC (XTA.LN) has the capacity to complete its current capital expenditure program without losing its investment grade rating or sacrificing its progressive dividend policy, the company's chief financial officer said Tuesday.

"Clearly, my primary priority was to enter this period of accelerated capital spend with a balance sheet that could sustain very extreme headwinds in terms of pricing," Trevor Reid told analysts in a call. "Given our outlook for commodities, even if you run a downside case, we still think we will be able to maintain a progressive dividend."

Xstrata said Tuesday that it would defer about $1 billion in capital expenditure this year, but that this wouldn't have any effect on the commissioning schedule of its projects.

It expects to make up for the deferred spending by increasing its capital spend by $400 million in 2013 and $600 million beyond that.

"We haven't cancelled any projects and we haven't moved back the scheduling for commissioning of any approved projects," Xstrata's Chief Executive Mick Davis told Dow Jones Newswires in an interview.

Xstrata now expects to spend $7.2 billion on capital expenditure in 2012, but said that the timing of its approved projects hasn't changed.

Mr. Reid told analysts that the company has very little flexibility in terms of adjusting its approved capital program.

"Obviously we could [adjust that] but it would be expensive to do and I think value destructive," he said, adding that the company does have flexibility in terms of the sequencing of its unapproved projects.

Write to Alex MacDonald at alex.macdonald@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

August 07, 2012 06:40 ET (10:40 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Rovsing mindsker driftsunderskud i første halvår og opjusterer

24-02-2017 16:36:15
Omsætningen i Rovsing, der har hovedkontor i Skovlunde ved København og blandt andet producerer testsystemer til satellitter og elektroniske produkter til rumin..

KORR. Genmab/Sydbank: Positiv anbefaling er godt nyt - og ventet

24-02-2017 14:04:12
(Korr: "uger" rettet til "måneder" i sjette afsnit)Det europæiske lægemiddelagenturs (EMA) komite for medicinske produkter for human anvendelse (CHMP) har givet..

Aktier/middag: Mærsk og Genmab i C20-bunden og dukkert til Rockwool

24-02-2017 11:44:51
Trods yderligere fremgang til ISS, der torsdag leverede et stærkt regnskab, ligger det danske aktiemarked fredag middag i et minus efter fald i aktier som Mærsk..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Lonmin PLC ORD USD0.0001 119,62 -2,2% Fald i aktiekurs
Glencore PLC ORD USD0.01 318,98 -3,7% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. februar 2017 02:24:04
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170217.2 - EUROWEB1 - 2017-02-26 02:24:04 - 2017-02-26 02:24:04 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x